Morepen Labs Reports Status of Physical Share Transfer Requests for December 2025
Morepen Laboratories Limited reported no physical share transfer requests were received, processed, or approved in December 2025. The status update is in line with SEBI's special window for re-lodgement of physical shares.
This is a routine administrative update related to share transfer processing under a SEBI directive. It does not involve any new business, financial results, or strategic decisions that would significantly impact the company.
The announcement provides a routine update on share transfer requests with no significant financial or operational changes reported. The status is neutral as there were no new requests or rejections.
Morepen Laboratories Limited has provided an update regarding the transfer requests of physical shares that were re-lodged under the special window granted by SEBI. The company, through its Registrar and Share Transfer Agent, MAS Services Limited, reported that for the month of December 2025, there were no requests received, processed, approved, or rejected.
As per the status report dated January 7, 2026, received from MAS Services Limited, the processing of any pending requests remains under process with no average time taken specified for December 2025. This update is in compliance with SEBI Circular No. SEBI/HO/MIRSD /MIRSD -PoD/P/CIR/2025/97 dated July 2, 2025, which provided a special six-month window for such re-lodgements.
The company's corporate office is located in Gurugram, Haryana, and its registered office is in Baddi, Himachal Pradesh.
What to do with a filing like this
Morepen Laboratories Limited filed this with the NSE as a statutory disclosure, categorised under share transfer updates. It is a primary document, not a recommendation, and the desk marks it low impact, the band that almost never moves a portfolio on its own.
That call is the part a filing cannot make for you. On RealCase, SEBI-registered research analysts and investment advisers read announcements like this one and turn the ones that matter into actions inside their model portfolios: a change in weight, a hold, or nothing at all. You are not left working out which of the roughly 250 filings published each day needs a response. The portfolio you follow is updated when a filing actually warrants it, with the reason written down.
See the model portfoliosA plain-language summary of a public exchange filing by Morepen Laboratories Limited. Read the original for the full detail.